Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains

Infection and Immunity

Volumn 69, Issue 2, 2001, Pages 1192-1198

  Gomez Duarte O G ^a   Pasetti, M F ^a   Santiago, A ^a   Sztein, M B ^a   Hoffman, S L ^a   Levine, M M ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PROTOZOAL PROTEIN; SALMONELLOSIS VACCINE; SPOROZOITE SURFACE PROTEIN 2; UNCLASSIFIED DRUG;

ALPHA HELIX; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN SECRETION; SALMONELLA ENTERICA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SPLEEN CELL; SPOROZOITE;

ANIMALS; ANTIGENS, PROTOZOAN; FEMALE; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MALARIA VACCINES; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SALMONELLA; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0035142760     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.2.1192-1198.2001     Document Type: Article

References (43)

1. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908
2. Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes
3. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model
4. Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: The dense alignment surface method
5. Oral somatic transgene vaccination using attenuated S. typhimurium
6. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model
7. The complexity of protective immunity against liver-stage malaria
8. + cell-, interferon gamma-, and nitric oxide-dependent immunity
9. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens
10. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA
11. Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: Secretion of the product enhances specific antibody responses in cattle
12. Development of antigen-delivery systems, based on the Escheriehia coli hemolysin secretion pathway
13. Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain
14. Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: Strain construction and safety and immunogenicity in humans
15. HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: Identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT
16. Immune effector mechanisms in malaria
17. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines
18. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis
19. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
20. Impact of intracellular location of and antigen display by intracellular bacteria: Implications for vaccine development
21. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein
22. + cytotoxic T-cell clone recognizing sporozoite surface protein 2
23. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors
24. Salmonella expressing protozoal antigens
25. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: Enhancement by exogenous tetrahydrobiopterin
26. Research toward vaccines against malaria
27. Quantification of antigen specific CD8+ T cells using an ELISPOT assay
28. Conversion of bacterial gene products to secretion-competent fusion proteins
29. Malaria vaccines: Multiple targets
30. Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA
31. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA
32. Attenuated guaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses
33. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors
34. Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: Expression during sporozoite ontogeny and binding to human hepatocytes
35. Characterization of Plasmodium falciparum sporozoite surface protein 2
36. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen
37. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
38. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: Involvement of interferon gamma and CD8+ T cells
39. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C
40. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans
41. Genetic analysis of the human malaria parasite Plasmodium falciparum
42. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers
43. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2